K-ras Mutation-Induced Resistance to Epidermal Growth Factor Receptor Inhibitors in Lung Cancer Cells

YANG Fan,CHEN Ke-zhong,LIU Hong-wei,SUI Xi-zhao,JIANG Guan-chao,WANG Jun,LI Jian-feng

DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2011.08.010

2011-01-01

Abstract:Objective By comparing the activity of signaling pathway in different cell lines affected by K-ras mutation, to investigate the resisitance to epidermal growth factor receptor (EGFR) inhibitors due to K-ras mutation. Methods Methyl thiazol tetrazolium (MTF) method was used to mensure the sensitivity and half maximal inhibitory concentration ( IC50 ) of AKT and STAT inhibitors after transfection of K-ras or blank plasmid into HCC827 and H292 cells. Western blotting was used to compare the activity of downstream signaling pathway in different cell lines. Results After transfection of mutant K-ras, the IC50 of AKT and STAT inhibitors in HCC827 cells was reduced by 1.9 and 5.3 times respectively, and that in H292 cells was reduced by 3.0 and 2. 0 times respectively. The activity of AKT and STAT pathways in HCC827 cells transfected with mutant K-ras was continuously activated, while that in H292 cells was suppressed. Conclusion K-ras-induced resistance to EGFR inhibitors may be related to other mechanisms. In the tumor cells bearing mutant or wild-type EGFR gene, there may exist different influences of K-ras mutations on AKT and STAT pathways.